• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒的可变中和抗原与保守中和抗原

Variable and conserved neutralization antigens of human immunodeficiency virus.

作者信息

Weiss R A, Clapham P R, Weber J N, Dalgleish A G, Lasky L A, Berman P W

出版信息

Nature. 1986;324(6097):572-5. doi: 10.1038/324572a0.

DOI:10.1038/324572a0
PMID:2431324
Abstract

Human immunodeficiency virus type 1 (HIV-1, HTLV-III/LAV), the retrovirus responsible for acquired immune deficiency syndrome (AIDS), shows a high degree of genetic polymorphism, particularly in the env gene. We have examined sera from rabbits and guinea pigs immunized with gp130, a recombinant env glycoprotein, and sera from HIV-1-infected subjects, to test their capacity to neutralize a panel of genetically divergent HIV-1 isolates. The sera raised against recombinant antigen specifically neutralized the virus strain from which the env gene was cloned (HTLV-IIIB), but not an independent isolate (HTLV-IIIRF). One rabbit serum tested on seven isolates cross-neutralized two at lower titres. In contrast, human sera from Britain and Uganda, chosen for ability to neutralize HTLV-IIIRF, cross-neutralized six other HIV-1 isolates. When serum and isolate were derived from the same subject, the serum was in some cases effective at slightly lower concentrations (higher titres). Human complement did not affect neutralization titres. These findings indicate that genetically diverse HIV-1 isolates carry both variable and widely conserved antigenic epitopes for neutralizing antibodies. The identification of shared epitopes may help the development of protective vaccines.

摘要

1型人类免疫缺陷病毒(HIV-1,即HTLV-III/LAV)是导致获得性免疫缺陷综合征(AIDS)的逆转录病毒,它表现出高度的基因多态性,尤其是在env基因中。我们检测了用重组env糖蛋白gp130免疫的兔和豚鼠的血清,以及HIV-1感染个体的血清,以测试它们中和一组基因不同的HIV-1分离株的能力。针对重组抗原产生的血清特异性中和了克隆env基因的病毒株(HTLV-IIIB),但不能中和一个独立的分离株(HTLV-IIIRF)。在七种分离株上检测的一份兔血清以较低滴度交叉中和了其中两种。相比之下,因能够中和HTLV-IIIRF而被挑选出来的英国和乌干达的人血清交叉中和了其他六种HIV-1分离株。当血清和分离株来自同一受试者时,血清在某些情况下在稍低浓度(更高滴度)时有效。人补体不影响中和滴度。这些发现表明,基因不同的HIV-1分离株带有可变的和广泛保守的中和抗体抗原表位。共同表位的鉴定可能有助于保护性疫苗的开发。

相似文献

1
Variable and conserved neutralization antigens of human immunodeficiency virus.人类免疫缺陷病毒的可变中和抗原与保守中和抗原
Nature. 1986;324(6097):572-5. doi: 10.1038/324572a0.
2
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.具有保守结构的1型人类免疫缺陷病毒中和表位在实验感染的黑猩猩中引发早期型特异性抗体。
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4478-82. doi: 10.1073/pnas.85.12.4478.
3
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.HIV(HTLV-III)感染中的中和抗体:与临床结局及针对不同病毒蛋白的抗体反应的相关性
Clin Exp Immunol. 1987 Aug;69(2):231-9.
4
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).针对人类嗜T细胞逆转录病毒(HTLV-I、-II、-III)所致疾病的疫苗的现状与策略
Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s.
5
Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.利用DNA免疫和重组痘苗病毒加强免疫筛选HIV-1 Env糖蛋白产生中和抗体的能力。
Virology. 1997 Apr 14;230(2):265-74. doi: 10.1006/viro.1997.8478.
6
Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.感染世界性HTLV-I的患者血清中不同的HTLV-I中和模式。
Virology. 1998 May 25;245(1):90-8. doi: 10.1006/viro.1998.9139.
7
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.用人免疫缺陷病毒env编码的合成肽抗体进行型特异性中和
Proc Natl Acad Sci U S A. 1988 Mar;85(6):1932-6. doi: 10.1073/pnas.85.6.1932.
8
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.黑猩猩持续感染人类免疫缺陷病毒:血清学反应及重新分离病毒的特性
J Virol. 1987 Oct;61(10):3173-80. doi: 10.1128/JVI.61.10.3173-3180.1987.
9
[Immunization against the human immunodeficiency virus in Zaire].[扎伊尔针对人类免疫缺陷病毒的免疫接种]
Med Trop (Mars). 1988 Oct-Dec;48(4):417-23.
10
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.长臂猿(白掌长臂猿)慢性感染人类免疫缺陷病毒1型后针对病毒包膜和核心抗原的细胞介导免疫反应
J Immunol. 1988 Oct 1;141(7):2467-73.

引用本文的文献

1
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
2
Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.关注缺口:B 细胞耐受对微生物抗体库的影响。
Immunol Rev. 2019 Nov;292(1):24-36. doi: 10.1111/imr.12805. Epub 2019 Sep 27.
3
A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.HIV 感染精英控制者体内高度异常的 Env V1 区。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.00094-19. Print 2019 May 15.
4
The expanding array of HIV broadly neutralizing antibodies.HIV 广谱中和抗体的不断增多。
Retrovirology. 2018 Oct 16;15(1):70. doi: 10.1186/s12977-018-0453-y.
5
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak.分析 HIV-1 包膜进化表明,在中国一次小规模暴发的前血浆供者中,抗体介导选择了常见表位。
Sci Rep. 2018 Apr 10;8(1):5743. doi: 10.1038/s41598-018-23913-2.
6
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies.使用重组腺相关病毒递送抗HIV抗体的前景与问题
Mol Ther Methods Clin Dev. 2016 Nov 16;3:16068. doi: 10.1038/mtm.2016.68. eCollection 2016.
7
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.一名病毒血症控制者体内强效HIV-1广谱中和抗体与抗体敏感病毒的共存情况。
Sci Transl Med. 2017 Jan 18;9(373). doi: 10.1126/scitranslmed.aal2144.
8
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.宿主内进化的纵向抗原序列和位点(LASSIE)可识别免疫选择的HIV变体。
Viruses. 2015 Oct 21;7(10):5443-75. doi: 10.3390/v7102881.
9
HIV-1 neutralizing antibodies: understanding nature's pathways.HIV-1 中和抗体:理解自然途径。
Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075.
10
Neutralizing antibodies to HIV-1 induced by immunization.免疫诱导的抗 HIV-1 中和抗体。
J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827.